Jong‐Mu Sun

5.3k total citations · 1 hit paper
82 papers, 2.1k citations indexed

About

Jong‐Mu Sun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jong‐Mu Sun has authored 82 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 54 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Jong‐Mu Sun's work include Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (26 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Jong‐Mu Sun is often cited by papers focused on Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (26 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Jong‐Mu Sun collaborates with scholars based in South Korea, United States and United Kingdom. Jong‐Mu Sun's co-authors include Keunchil Park, Myung‐Ju Ahn, Jin Seok Ahn, Se‐Hoon Lee, Hyun Ae Jung, Hong Sook Kim, Jung Kyoon Choi, Manel Esteller, Jeong Yeon Kim and Hyunchul Jung and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jong‐Mu Sun

81 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

2019 322 citations Hong Sook Kim, Jong‐Mu Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jong‐Mu Sun South Korea	25	1.3k	1.1k	528	431	237	82	2.1k
Yann Vano France	23	1.4k 1.1×	1.2k 1.1×	770 1.5×	547 1.3×	289 1.2×	83	2.4k
S. Cedrés Spain	20	1.3k 1.0×	1.2k 1.1×	363 0.7×	272 0.6×	211 0.9×	80	2.2k
Sylvestre Le Moulec France	21	1.3k 1.0×	919 0.8×	706 1.3×	583 1.4×	138 0.6×	97	2.3k
Naoki Kanomata Japan	22	840 0.6×	528 0.5×	549 1.0×	337 0.8×	216 0.9×	104	1.7k
Seiji Sakata Japan	18	1.1k 0.9×	1.2k 1.1×	766 1.5×	561 1.3×	201 0.8×	39	2.2k
Leila Khoja United Kingdom	20	1.7k 1.3×	612 0.5×	416 0.8×	388 0.9×	159 0.7×	50	2.1k
Susanna Cappia Italy	24	766 0.6×	748 0.7×	651 1.2×	363 0.8×	387 1.6×	56	2.0k
Yungan Tao France	27	1.0k 0.8×	660 0.6×	586 1.1×	248 0.6×	756 3.2×	112	2.3k
Genichiro Ishii Japan	30	997 0.8×	1.3k 1.2×	588 1.1×	425 1.0×	374 1.6×	95	2.6k
Leigh Marcus United States	12	1.1k 0.8×	488 0.4×	279 0.5×	457 1.1×	311 1.3×	18	1.6k

Countries citing papers authored by Jong‐Mu Sun

Since Specialization

Citations

This map shows the geographic impact of Jong‐Mu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong‐Mu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong‐Mu Sun more than expected).

Fields of papers citing papers by Jong‐Mu Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong‐Mu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong‐Mu Sun. The network helps show where Jong‐Mu Sun may publish in the future.

Co-authorship network of co-authors of Jong‐Mu Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jong‐Mu Sun. A scholar is included among the top collaborators of Jong‐Mu Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong‐Mu Sun. Jong‐Mu Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Sehhoon, Jong‐Mu Sun, Se‐Hoon Lee, et al.. (2025). A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer. European Journal of Cancer. 230. 115805–115805. 1 indexed citations

Park, Sehhoon, Hyun Ae Jung, Jong‐Mu Sun, et al.. (2024). Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer (BLOSSOM). Journal of Clinical Oncology. 42(23). 2747–2756. 23 indexed citations

Jung, Hyun Ae, Sehhoon Park, Jong‐Mu Sun, et al.. (2023). Expanded Access Program Pralsetinib in Advanced Non–Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement. Cancer Research and Treatment. 55(4). 1144–1151. 3 indexed citations

Jung, Hyun Ae, Bo Mi Ku, Yeon Jeong Kim, et al.. (2023). Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 18(9). 1199–1208. 37 indexed citations

Lee, Jiyun, Jiae Koh, Hee Kyung Kim, et al.. (2022). Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 Trial. Journal of Thoracic Oncology. 17(7). 900–908. 21 indexed citations

Kim, Kyung Hwan, Hongryull Pyo, Hoyoung Lee, et al.. (2022). Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy. International Journal of Radiation Oncology*Biology*Physics. 113(2). 415–425. 13 indexed citations

Jeong, Byeong‐Ho, Yeonghee Eun, Cheol‐In Kang, et al.. (2021). Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experience. European Journal of Cancer. 159. 167–173. 11 indexed citations

Byeon, Seonggyu, Jang Ho Cho, Hyun Ae Jung, et al.. (2020). PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence. Cancer Medicine. 9(7). 2352–2362. 32 indexed citations

Kim, Y., Chul‐Hwan Kim, Hyoyoung Lee, et al.. (2019). OA14.07 Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced NSCLC Treated with Immunotherapy. Journal of Thoracic Oncology. 14(10). S245–S245. 1 indexed citations

10.

Kim, Hong Sook, Hongui Cha, Jin-Ho Kim, et al.. (2019). Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing. European Journal of Cancer. 120. 65–74. 34 indexed citations

11.

Lee, Kyung Soo, Joon Young Choi, Myung Jin Chung, et al.. (2018). Surgically resected T1‐ and T2‐stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT. Cancer Medicine. 7(8). 3561–3570. 14 indexed citations

12.

Park, Hyunjin, Ho Yun Lee, Insuk Sohn, et al.. (2018). Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach. Scientific Reports. 8(1). 8968–8968. 11 indexed citations

13.

Cho, Jong Ho, Wei Zhou, Yoon‐La Choi, et al.. (2017). Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer. Cancer Research and Treatment. 50(1). 95–102. 26 indexed citations

14.

Ahn, Myung‐Ju, Sung Hee Lim, Jong‐Mu Sun, et al.. (2016). Efficacy and safety of dovitinib in pretreated advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase II study. Journal of Thoracic Oncology. 11(2). S16–S16. 5 indexed citations

15.

Yoo, Chang Eun, Hui‐Sung Moon, Yeon Jeong Kim, et al.. (2015). Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cells. Biomaterials. 75. 271–278. 33 indexed citations

16.

Ha, Sang Yun, In Ho Choi, Joungho Han, et al.. (2014). Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement. Lung Cancer. 83(3). 411–415. 18 indexed citations

17.

Sun, Jong‐Mu, Maruja E. Lira, Kinnari Pandya, et al.. (2013). Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma. Lung Cancer. 83(2). 259–264. 26 indexed citations

18.

Park, Lee Chun, Jun Ho Ji, Silvia Park, et al.. (2012). Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation. Cancer Chemotherapy and Pharmacology. 70(2). 315–320. 15 indexed citations

19.

Sun, Jong‐Mu, Joon Oh Park, Young‐Woong Won, et al.. (2010). Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection of Patients for Maintenance Therapy. Journal of Thoracic Oncology. 5(4). 540–545. 25 indexed citations

20.

Kim, Dong‐Wan, Jong‐Mu Sun, Do‐Youn Oh, et al.. (2003). An Analysis of Treatment Results of Lymphoblastic Lymphoma in Adults According to the Chemotherapy Regimens. Blood Research. 38(1). 32–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact